Provided by Tiger Fintech (Singapore) Pte. Ltd.

CHINARES PHARMA

5.350
+0.1102.10%
Volume:12.52M
Turnover:66.48M
Market Cap:33.61B
PE:9.24
High:5.390
Open:5.240
Low:5.230
Close:5.240
Loading ...

China Resources Pharmaceutical Group Ltd. Held Annual General Meeting

Reuters
·
23 May

CR Sanjiu, Subsidiary of China Resources Pharmaceutical, Expands Pharmaceutical Product Line

Reuters
·
14 May

China Resources Pharmaceutical - Qtrly Net Profit for Tasly Pharmaceuticals RMB332.1 Mln

THOMSON REUTERS
·
28 Apr

Jiang Zhong Pharmaceutical's Q1 Profit Increases

MT Newswires Live
·
28 Apr

BRIEF-China Resources Pharmaceutical Says QTRLY Net Profit Rmb425.0 Million For Dong-E-E-Jiao

Reuters
·
28 Apr

China Resources Pharmaceutical - Qtrly Net Profit of Jiangzhong Pharmaceutical RMB306.7 Mln

THOMSON REUTERS
·
28 Apr

China Resources Pharmaceutical - Qtrly REV of Jiangzhong Pharmaceutical RMB1.18 Bln

THOMSON REUTERS
·
28 Apr

China Resources Pharma Unit Issues 400 Million Yuan of Bonds

MT Newswires Live
·
25 Apr

BRIEF-China Resources Pharmaceutical Posts Qtrly Results For China Resources Boya Bio-Pharmaceutical

Reuters
·
25 Apr

China Resources Pharmaceutical - Qtrly Net Profit for China Resources Boya Bio-Pharmaceutical RMB139.3 Mln

THOMSON REUTERS
·
25 Apr

Stock Track | China Resources Pharmaceutical Plummets 5.13% Following Disappointing 2024 Profit Results

Stock Track
·
26 Mar

China Resources Pharmaceutical's 2024 Profit Slides; Shares Fall 4%

MT Newswires Live
·
26 Mar

BRIEF-China Resources Pharmaceutical Says FY Net Profit Attributable For Jiangzhong Pharmaceutical Was RMB788.2 Million

Reuters
·
19 Mar

China Resources Pharmaceutical - Cash Dividend of RMB7.00 for Every 10 Shares of Jiangzhong Pharmaceutical

THOMSON REUTERS
·
19 Mar

BRIEF-China Resources Pharmaceutical Posts FY Results For CR Double-Crane Pharmaceutical

Reuters
·
19 Mar

China Resources Pharmaceutical - FY Net Profit Attributable for China Resources Double-Crane Pharmaceutical RMB1.63 Bln

THOMSON REUTERS
·
19 Mar

China Resources Pharmaceutical Posts FY Net Profit Attributable Of CR Boya Bio-Pharmaceutical Of RMB397 Million

Reuters
·
18 Mar

China Resources Pharmaceutical - FY Net Profit Attributable of Cr Boya Bio-Pharmaceutical RMB397 Mln

THOMSON REUTERS
·
18 Mar

China Resources Pharmaceutical Posts FY Revenue RMB5.92 Bln For Dong-E-E-Jiao

Reuters
·
18 Mar

China Resources Pharmaceutical - FY Net Profit Attributable for Dong-E-E-Jiao RMB1.56 Bln

THOMSON REUTERS
·
17 Mar